文献速递慢性静脉疾病

激光消融与机械化学消融治疗原发性静脉曲张的随机临床试验

Laser ablation versus mechanochemical ablation in the treatment of primary varicose veins: A randomized clinical trial.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2019-12-19

本研究前瞻性纳入100例原发性静脉曲张患者,随机均分为腔内激光消融(EVLA)组与机械化学消融(MOCA)组各50例,比较治疗成功率。结果显示两组手术均全部成功,MOCA组手术时间更短、静脉临床严重程度评分更低、术后静脉炎发生率更低且恢复工作更快,术后12个月生活质量改善组间无显著差异。

要点

  • MOCA组手术时间明显短于EVLA组,两组手术成功率均为100%。
  • MOCA组术后静脉炎发生率显著低于EVLA组,恢复工作更快。
  • 两组随访12个月静脉临床严重程度评分与生活质量均改善。

核心结论

  • 对原发性静脉曲张,MOCA是可行、有效且安全的术式,与EVLA相比临床结局更优、术后静脉炎发生率更低。

研究设计与样本

  • 前瞻性随机临床试验,共纳入100例原发性静脉曲张患者,EVLA组50例、MOCA组50例。
  • 干预前均行临床与超声血管评估,采用静脉临床严重程度评分评估临床严重度,并填写慢性静脉功能不全问卷。
  • 主要研究结局为治疗成功率,术后1周、1个月、6个月和12个月随访。

主要发现

  • 所有患者均取得手术成功。
  • MOCA组手术时间较EVLA组显著缩短。
  • 随访期间两组静脉临床严重程度评分均显著改善,且MOCA组显著更低。
  • 两组术后感知疼痛均显著改善,组间无显著差异。
  • 术后12个月慢性静脉功能不全问卷显著改善,组间无显著差异;MOCA组术后静脉炎发生率显著更低、恢复工作时间显著更短。

临床怎么用

  • 对原发性静脉曲张可在EVLA与MOCA间选择,MOCA在手术时间、术后静脉炎和恢复工作方面可能更有优势。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: to prospectively compare the surgical outcome of using endovenous laser ablation (EVLA) and mechanochemical ablation (MOCA) in management of patients with primary varicose veins (VV). METHODS: The present study prospectively recruited 100 patients with primary VV. They were randomly and equally allocated to one of two treatment group: the EVLA group (n = 50) or the MOCA group (n = 50). Before intervention, all patients underwent to clinical and ultrasound assessment of the vascular system. The Venous Clinical Severity Score was used to assess clinical severity. In addition, patients completed the Chronic Venous Insufficiency Questionnaire. The primary study outcome was treatment success. After intervention, patients were followed up at 1 week, 1 months, 6 months, and 12 months. RESULTS: Operative success was achieved in all patients. The MOCA group had a significantly shorter operative time when compared with EVLA group. The Venous Clinical Severity Score significantly improved in both groups over the follow-up period and showed significantly lower levels in the MOCA group. Perceived pain was significantly improved in both groups postoperatively with no significant differences. The Chronic Venous Insufficiency Questionnaire was significantly improved after 12 months of operation without significant differences between groups. MOCA patients had significantly lower rate of postoperative phlebitis and significantly shorter time to return to work. CONCLUSIONS: MOCA for primary VV is a feasible, effective, and safe procedure with better clinical outcome and lower rate of postoperative phlebitis when compared with EVLA.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Tawfik AM, Sorour WA, El-Laboudy ME, et al. Laser ablation versus mechanochemical ablation in the treatment of primary varicose veins: A randomized clinical trial. J Vasc Surg Venous Lymphat Disord. 2019. PMID: 31864932. doi:10.1016/j.jvsv.2019.10.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。